Diabetic ischemic optic neuropathy
Conditions
Interventions
Test group:The treatment of the primary disease+ Insulated body needles and low-power needling of the Shangjingming point and Qiuhou point
Control group:The treatment of the primary disease+ Conventional western medicine
Sponsors
Xiyuan Hospital of CACMS
Eligibility
Sex/Gender
All
Age
45 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) Meet the diagnosis of diabetic ischemic optic neuropathy. (2) Be between the ages of 45-75 years, (both 45 and 75 years) for both sexes. (3) Have not participated in any other clinical studies in the last 3 months. (4) Those who are informed about the study, sign the informed consent form, and voluntarily participate in and cooperate with the trial.
Exclusion criteria
Exclusion criteria: (1) Those who do not meet the diagnosis of diabetic ischemic optic neuropathy; (2) Those with broken skin at the site of acupuncture point extraction; (3) Those who have undergone fundus total retinal photocoagulation treatment; (4) Those who have combined glaucoma, serious diseases affecting the refractive system such as corneal disease, crystal dislocation, or serious fundus abnormalities such as acute fundus hemorrhage; (5) Combined with serious cardiac, cerebrovascular, hepatic and renal and other systemic diseases, long-term use of anticoagulant drugs and coagulation disorders; (6) Those who have a history of allergy to methylcobalamin, procaine and acupuncture needle metal; (7) Pregnant and lactating women; (8) Those who are participating in other clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Best corrected visual acuity (BCVA);Visual field indicators;Optic disk blood flow ; | — |
Secondary
| Measure | Time frame |
|---|---|
| Intraocular pressure (IOP);Safety indicators; | — |
Countries
China
Contacts
Public ContactLiqun Chu
Xiyuan Hospital of CACMS
Outcome results
None listed